ProCE Banner Activity

An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers

Slideset Download
Download this slideset for an expert overview of HER2 testing in metastatic breast and GI cancers and the use novel HER2, HER3, and TROP2-targeted therapeutics for these malignancies.

Released: October 29, 2020

Expiration: October 28, 2021

No longer available for credit.

Share

Faculty

Mark D. Pegram

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Axel Grothey

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

Michael F. Press

Michael F. Press, MD, PhD

Harold E. Lee Chair in Cancer Research
Professor of Pathology
Department of Pathology
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Program Director Disclosure

Program Director

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Faculty Disclosure

Primary Author

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

Michael F. Press, MD, PhD

Harold E. Lee Chair in Cancer Research
Professor of Pathology
Department of Pathology
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California